Human umbilical cord mesenchymal stem cell not checked
Sclnow Biotechnology Co., Ltd.
FollowEvery change as it happens, and a Monday email
Trials
3 active
5 in total
Targets
—
None known yet
What this is
- How it works
- How it works isn't classified yet
- How it’s given
- “Human umbilical cord mesenchymal stem cells (SCLnow 19#): group A, 1 \* 10\^7 cells (5ml);”In the company’s words, NCT03383081 on ClinicalTrials.gov
- Tested for
- Osteoarthritis, Knee, Spinocerebellar Ataxia Type 1, Spinocerebellar Ataxia Type 2, Spinocerebellar Ataxia Type 3, Spinocerebellar Ataxia Type 6, Lumbar Discogenic Pain
- Main trialPhase 2
- “The purpose of this study is verify the efficacy and safety of Human Umbilical Cord Mesenchymal Stem Cells (UC-MSC) therapy for patients with Osteoarthritis, and in addition, provide basis for exploring the treatment regimen of UC-MSC therapy in different degree of cartilage defect disease”In the company’s words, NCT03383081 on ClinicalTrials.gov
- Other names
- mesenchymal stem cells · umbilical cord mesenchymal stem cell
Other drugs for Osteoarthritis, Knee
- JointstemR-Bio · Phase 3
- DiacereinTRB Chemedica · Phase 3
- Mesenchymal Stem CellsWuxi Cellular Biopharmaceutical Group Ltd. · Phase 3
- PTP-01Doron Therapeutics Inc. · Phase 3
- Sodium hyaluronateIBSA Institut Biochimique SA · Phase 3
- Pentosan Polysulfate SodiumParadigm Biopharmaceuticals Ltd. · Phase 3
Coming up3
- 31 DecPhase 2 trial completes · ClinicalTrials.gov
- 31 DecPhase 1 trial completes · ClinicalTrials.gov
- 30 Jun 2027Phase 2 trial completes · ClinicalTrials.gov
Changes1
Last 90 days- 18 NovCompletion date moved: 2026-06-30 to 2026-12-31 · ClinicalTrials.gov NCT03383081
Trials5
| Trial | Phase | Completes | What it tests |
|---|---|---|---|
| Phase 2Recruiting | 31 Dec 2026 | The Safety/Efficacy of hUC Mesenchymal Stem Cells(19#iSCLife®-OA) Therapy for Patients With Osteoarthritis | |
| Phase 2Not yet recruiting | 30 Jun 2027 | Umbilical Cord Mesenchymal Stem Cells Therapy (19#iSCLife®-SA) for Patients With Spinocerebellar Ataxia | |
| Phase 1Recruiting | 31 Dec 2026 | The Safety/Efficacy Study of Human Umbilical Cord Mesenchymal Stem Cells Therapy (19#iSCLife®-LDP) for Lumbar Discogenic Pain | |
| Phase 1Completed | 1 Jun 2021 | hUC Mesenchymal Stem Cells (19#iSCLife®-CSD) Therapy for Patients With Healing Poor After Uterus Injury | |
| Phase 1Suspended | 30 Jun 2027 | SCLife®-LDD hUC-MSCs Injection Therapy for Patients With Lumbar Intervertebral Disc Degeneration |
A trial in both registries shows both numbers.
About
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 · EU trials register (CTIS) updated 19 Nov 2026 · openFDA updated 19 Nov 2026